Next Article in Journal
ERBB2 Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma
Next Article in Special Issue
LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer
Previous Article in Journal
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia
Previous Article in Special Issue
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
 
 
Article

Article Versions Notes

Cancers 2023, 15(9), 2413; https://doi.org/10.3390/cancers15092413
Action Date Notes Link
article xml file uploaded 22 April 2023 11:49 CEST Original file -
article xml uploaded. 22 April 2023 11:49 CEST Update -
article pdf uploaded. 22 April 2023 11:49 CEST Version of Record https://www.mdpi.com/2072-6694/15/9/2413/pdf-vor
article supplementary file uploaded. 22 April 2023 11:49 CEST - https://www.mdpi.com/2072-6694/15/9/2413#supplementary
article html file updated 22 April 2023 11:51 CEST Original file -
article xml file uploaded 24 April 2023 03:13 CEST Update -
article xml uploaded. 24 April 2023 03:13 CEST Update https://www.mdpi.com/2072-6694/15/9/2413/xml
article pdf uploaded. 24 April 2023 03:13 CEST Updated version of record https://www.mdpi.com/2072-6694/15/9/2413/pdf
article html file updated 24 April 2023 03:14 CEST Update https://www.mdpi.com/2072-6694/15/9/2413/html
Back to TopTop